A simple method to cure established tumors by inflammatory killing of normal cells
- 1 August 2004
- journal article
- research article
- Published by Springer Nature in Nature Biotechnology
- Vol. 22 (9) , 1125-1132
Abstract
We describe a simple technology used to cure an established metastatic disease. Intradermal injection of plasmid DNA encoding a transcriptionally targeted cytotoxic gene, along with hsp70, not only promoted tissue-specific, inflammatory killing of normal melanocytes, but also induced a CD8+ T-cell–dependent, antigen-specific response in mice that eradicated systemically established B16 tumors. This CD8+ T cell response was subsequently suppressed in vivo within a few days. The data demonstrate that deliberate destruction of normal tissue can be exploited to generate immunity against a malignant disease originating from that tissue. This approach obviates the need to identify tumor antigens and does not require complex isolation of tumor cells or their derivatives. In addition, it provides a model system for studying the mechanisms underlying the etiology and control of autoimmune diseases. Finally, despite targeting normal tissue, therapy could be separated from development of overt autoimmune symptoms, suggesting that the strategy may be valuable against tumors derived from both non-essential and essential tissue types. *Note: In the version of this article originally published online, the name of one of the authors was spelled incorrectly. Mayoi Lai should be Maoyi Lai. This mistake has been corrected in the HTML version and will appear correctly in print.Keywords
This publication has 37 references indexed in Scilit:
- HSP70 Peptide Binding Mutants Separate Antigen Delivery from Dendritic Cell StimulationImmunity, 2004
- Tumor Regression and Autoimmunity after Reversal of a Functionally Tolerant State of Self-reactive CD8+ T CellsJournal of Experimental Medicine, 2003
- Cancer Regression and Autoimmunity in Patients After Clonal Repopulation with Antitumor LymphocytesScience, 2002
- Antigen Presentation by Dendritic Cells In VivoJournal of Experimental Medicine, 2002
- The enemy within: keeping self-reactive T cells at bay in the peripheryNature Reviews Immunology, 2002
- Elucidating the Autoimmune and Antitumor Effector Mechanisms of a Treatment Based on Cytotoxic T Lymphocyte Antigen-4 Blockade in Combination with a B16 Melanoma VaccineJournal of Experimental Medicine, 2001
- Role of Bone Marrow-Derived Cells in Presenting MHC Class I-Restricted Tumor AntigensScience, 1994
- T cell receptor antagonist peptides induce positive selectionCell, 1994
- Tumor immunity as autoimmunity: tumor antigens include normal self proteins which stimulate anergic peripheral T cellsImmunology Today, 1993
- Melanocyte stimulating hormone activation of tyrosinase in B16 mouse melanoma cells Evidence for a differential induction of two distinct isoenzymesFEBS Letters, 1992